ArticleApplied biochemistry and biotechnology2025
Cold Plasma Treatment Facilitated the Conversion of Lignin-Derived Aldehyde for Pseudomonas putida.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Parameter Optimization and Regulatory Mechanism of Cold Plasma Pretreatment for Enhancing Intracellular Polysaccharides Yield in Irpex lacteus.Applied biochemistry and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Syringaldehyde derived from lignin is one of the essential intermediates for the production of basic chemicals. However, it was poorly understood for the direct microbial conversion of syringaldehyde. Here, this study tried to use cold plasma technique to enhance syringaldehyde conversion for the bacterium Pseudomonas putida. It illustrated that cell growth and syringaldehyde conversion were separately increased by 1.49 times at 3 h and 1.60 times at 6 h for 35 s, 1.16 and 3.44 times for 140 W, and 1.63 and 4.02 times for 105 Pa for P. putida through single factor assays of cold plasma treatment. To be sure, cell growth and syringaldehyde conversion were enhanced by 1.14 and 5.54 times at 3 h under the optimum parameters (35 s, 140 W, and 105 Pa) for P. putida. Furthermore, genome re-sequencing further discovered single-nucleotide polymorphisms of P. putida, such as PP_2589 (A428V), PP_5651 (V82F), and PP_0545 (W335R), and thus indicated that the potential genetic changes derived from cold plasma treatment would be responsible for the acceleration of syringaldehyde conversion. This work would provide a robust strain catalyst and the potential candidate mutation sites for genetic manipulation for microbial bioconversion of the value-added and lignin-based biochemicals.
Indexed as
Identifiers
39570516What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.